封面
市場調查報告書
商品編碼
1308630

2030 年生物可吸收聚合物市場預測:按產品類型、應用和地區劃分的全球分析

Bioresorbable Polymers Market Forecasts to 2030 - Global Analysis By Product Type, Application, and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC 的數據,2023 年全球生物可吸收聚合物市場規模將達到15.2 億美元,預測期內復合年增長率為15.7%,到2030 年將達到42 億美元。預計將達到3000萬美元。

生物可吸收聚合物是醫療行業中常用的物質,因為它們可以被人體安全吸收。 一旦這些聚合物被植入體內,就不需要剝落。 另外,生物可吸收聚合物在醫療行業中的使用會降解生物可吸收聚合物,例如聚乳酸(PLA)、聚乙交酯(PGA)和PLA/PGA的共聚物。 對於將非結構化藥物輸送到可吸收螺釘和錨釘中,這些材料可以根據機械性能和吸收率進行定制,這將推動市場增長。

市場動態:

驅動程序

優惠贖回

推動生物可吸收聚合物市場擴張的主要因素之一是許多外科手術的有利報銷情況。 例如,CMS USA 提供全球手術套餐,旨在支付所有手術護理費用,包括外科醫生為美國公民提供的術前、術中和術後護理。 因此,由於保險覆蓋範圍的擴大導致外科手術數量不斷增加,預計未來幾年生物可吸收聚合物的市場發展將會增長。

限制

缺乏熟練工人

由於該領域的發展,基於生物可吸收材料的醫療產品的技術前景和應用正在迅速發展。 這要求醫生和其他醫療保健專業人員具備管理由生物可吸收材料製成的藥物的必要技能。 因此,外科醫生和醫療服務醫生不使用複雜的生物可吸收醫療產品來閉合傷口。

機會:

藥物輸送應用對生物可吸收聚合物的需求不斷增長

聚合物通過實現循環給藥、固定劑量治療劑的時間控制釋放以及親水性和疏水性藥物的差異釋放,極大地改進了藥物遞送技術。 自早期使用傳統材料以來,該領域已經取得了長足的進步。 現代藥物輸送領域的突破現在建立在針對特定貨物的聚合物的合理設計之上,旨在發揮獨特的生物活性。 生物可吸收聚合物能夠用配體進行表面修飾,從而實現隱私和人體內的靶向藥物輸送。 它還允許受控釋放到所需位置、對不平衡分子(例如蛋白質)穩定以及對不平衡分子穩定。

威脅

與傳統塑料相比成本較高

與可降解聚合物和其他聚合物相比,生物可吸收聚合物的市場在很大程度上受到其高成本的限制。 儘管預計該市場將以更快的速度發展,但與傳統聚合物市場相比仍然很小。 因此,傳統聚合物的生產受益於規模經濟,而生物可吸收聚合物的生產規模較小。 結果,製造成本增加並且對成品的需求增加。 然而,生物可吸收聚合物僅需要一次性處理,從而改善了整體服務。 從長遠來看,此類聚合物高成本的影響是可以減輕的。

新冠肺炎 (COVID-19) 影響:

鼠疫流行幾乎影響著文明的各個方面。 由於全球供應鏈中斷和規劃流程延遲,生物可吸收聚合物市場經歷了放緩。 醫療行業需求下降是這個問題的根源。 原材料供應短缺,貨物到達目的地需要很長時間。 然而,隨著醫療和製藥領域對生物可吸收聚合物的需求增加,市場開始復蘇。 疫情期間醫療行業繼續運轉,支撐了全球市場。 2021 年開展廣泛的疫苗接種運動後,更多發展中國家擴大了生物可吸收聚合物的生產。

預計聚乳酸細分市場在預測期內將成為最大的細分市場:

聚乳酸部分由於其優異的加工性能和機械強度而預計將獲得利潤豐厚的增長,使 PLA 成為最具商業可行性的生物聚合物之一。 PLA 無毒、可生物降解、可回收、可堆肥並可被生物體代謝。 它們在許多方面都優於傳統聚合物,例如改進的熱加工性和各種成型工藝的可能性。 PLA 的兩個主要亞型是 PLLA 和 PDLLA。

預計骨科器械領域在預測期內復合年增長率最高:

預計骨科器械設備領域在預測期內復合年增長率最高。 這一應用的高速增長是由於骨科疾病的患病率不斷增加、人均收入增加導致生活水平不斷提高、醫療保健支出不斷增加、世界各國對更優質醫療保健和生物可吸收支架的需求不斷增加。多種因素,包括人們認識的提高

份額最大的地區:

由於新興市場經濟快速擴張和人均可支配收入不斷上升,亞太地區預計將在預測期內佔據最大的市場份額。 印度、中國和日本等高增長國家、人口迅速老齡化、醫院數量不斷增加、支持性報銷政策、有利的政府舉措的實施、人均收入的上升以及對衛生部門的重大貢獻。尖端外科產品以及私立醫院向農村地區的擴張是推動亞太地區市場的其他因素。

複合年增長率最高的地區:

由於骨科和藥物輸送應用中的產品使用量增加,預計北美在預測期內將呈現最高的複合年增長率。 北美生物可吸收聚合物市場受到醫療領域重要研發中心美國的進一步刺激。 此外,骨科和藥物輸送應用對聚合物的需求不斷增長以及醫療支出的增加預計將推動該地區的產品需求。

主要進展:

2023年6月,贏創將在新加坡建造一座新工廠,以在全球範圍內拓展其醇鹽業務。 未來,醇鹽催化劑也將通過在PET塑料的化學回收中的使用,在循環經濟中發揮重要作用。

報告內容

  • 區域和國家層面的市場細分
  • 給新進入者的戰略建議
  • 2021 年、2022 年、2023 年、2026 年和 2030 年的綜合市場數據
  • 市場趨勢
  • 根據市場預測提出關鍵業務領域的戰略建議
  • 競爭格局繪製主要共同趨勢
  • 公司簡介,包括詳細的戰略、財務狀況和最新發展
  • 供應鏈趨勢映射最新技術趨勢

免費定制服務:

訂閱此報告的客戶將獲得以下免費自定義選項之一:

  • 公司簡介
    • 對其他市場參與者(最多 3 家公司)進行全面分析
    • 主要公司的SWOT分析(最多3家公司)
  • 區域細分
    • 根據客戶興趣對主要國家/地區的市場估計/預測/複合年增長率(注:基於可行性檢查)
  • 競爭基準測試
    • 根據產品組合、地域分佈和戰略聯盟對主要參與者進行基準測試

內容

第 1 章執行摘要

第二章前言

  • 執行摘要
  • 利益相關者
  • 調查範圍
  • 調查方法
    • 數據挖掘
    • 數據分析
    • 數據驗證
    • 研究方法
  • 調查來源
    • 主要研究來源
    • 二手研究來源
    • 先決條件

第三章市場趨勢分析

  • 驅動程序
  • 制約因素
  • 機會
  • 威脅
  • 產品分析
  • 使用情況分析
  • 新興市場
  • 新冠肺炎 (COVID-19) 的影響

第 4 章波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間存在敵對關係

第五章全球生物可吸收聚合物市場:按產品類型

  • 多醣
  • 聚乳酸
    • 聚-DL-乳酸 (PDLLA)
    • 聚左旋乳酸 (PLLA)
  • 聚乙醇酸
  • 聚己內酯
  • 乳酸和乙醇酸的共聚物(PLGA)
  • 農業聚合物
  • 生物聚酯
  • 其他產品類型

第 6 章全球生物可吸收聚合物市場:按應用分類

  • 矯形裝置
    • 髖關節
    • 膝關節
    • 外傷
    • 脊柱
  • 藥物輸送
    • 注射用
    • 口頭
    • 其他藥物輸送
  • 其他用途

第 7 章:生物可吸收聚合物的全球市場:按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 意大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 新西蘭
    • 韓國
    • 亞太地區其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 卡塔爾
    • 南非
    • 其他中東/非洲

第 8 章主要進展

  • 合同、合作夥伴關係、聯盟和合資企業
  • 收購與合併
  • 推出新產品
  • 業務擴展
  • 其他關鍵策略

第 9 章公司簡介

  • Evonik Industries AG
  • Foster Corporation
  • Ashland Global Holdings Inc.
  • REVA Medical, LLC
  • Bezwada Biomedical, LLC
  • BMG Incorporated
  • Foryou Medical Devices Co., Ltd
  • Musashino Chemical Laboratory, Ltd.
  • Henan Xinghan Biotechnology Co. Ltd.
  • KLS Martin Group
  • DSM Biomedical
  • Corbion N.V.
  • Zeus Industrial Products
  • Abbott
  • 3D Biotek LLC
  • Sunstar Suisse S.A.
  • Futerro
Product Code: SMRC23330

According to Stratistics MRC, the Global Bioresorbable Polymers Market is accounted for $1.52 billion in 2023 and is expected to reach $4.23 billion by 2030 growing at a CAGR of 15.7% during the forecast period. Bioresorbable polymers are substance that is frequently utilised in the healthcare industry because it may be safely absorbed by the body. When these polymers are planted on the body, they do not need to be dethatched. Moreover, the utilization of the Bioresorbable polymers in the healthcare industry breaks down bioresorbable polymers such polylactide (PLA), polyglycolide (PGA), and copolymers of PLA/PGA. For the non-structural drug delivery to resorbable screws and anchors, these materials may be customised to match mechanical performance and resorption rates which drive the growth of the market.

Market Dynamics:

Driver:

Favourable reimbursement

One of the main factors propelling the expansion of the bioresorbable polymers market is the favourable reimbursement status for a number of surgical procedures. For instance, the US CMS offers the worldwide surgical package, which aims to cover payments for all surgical treatments which includes preoperative, intraoperative, and postoperative carried out by surgeons for US citizens. As a result, the market for bioresorbable polymers is anticipated to develop over the next few years as a result of the rising number of surgical operations brought on by better insurance coverage.

Restraint:

Lack of skilled personnels

Due to developments in this area, the technical landscape and applications for medical goods based on bioresorbable materials are developing quickly. This urges doctors and other healthcare professionals to have the skills necessary to manage medicinal goods made of bioresorbable materials. As a result, sophisticated bioresorbable medical items are not used for wound closure by medical surgeons or doctors from healthcare services.

Opportunity:

Increasing demand for bioresorbable polymers for drug delivery applications

By permitting cyclic dosing, controlled release of therapeutic agents in constant amounts throughout time, and different releases of both hydrophilic and hydrophobic medications, polymers have considerably improved drug delivery technology. Since its early days of using ordinary materials, the field has substantially grown. Modern breakthroughs in drug delivery are now built on the rational design of polymers intended to exert unique biological activities and tailored for a particular cargo. Bioresorbable polymers have the capacity to change surfaces with ligands for privacy and targeted drug administration in the human body. They also allow regulated release to the desired place, stability to unbalanced molecules (such as proteins), and stability to imbalanced molecules.

Threat:

High cost when compared to traditional plastics

The market for bioresorbable polymers is severely constrained by the higher cost of bioresorbable polymers compared to degradable and other polymers. Although the market anticipates a faster pace of development, it is still smaller than the market for traditional polymers. As a result, the manufacturing of traditional polymers benefits from economies of scale, whereas the production of bioresorbable polymers is small-scale. As a result, the cost of production is greater, boosting demand for the finished product. Bioresorbable polymers, however, provide a one-time fix and improved services overall. Long-term, this can lessen the impact of these polymers' greater cost.

COVID-19 Impact:

The epidemic has had an impact on almost every facet of civilization. The market for bioresorbable polymers has seen a downturn as a result of the interruptions in the global supply chain and the delays in planned processes. The medical industry's declining demand was the root of this problem. Raw resources were scarce, and it took longer for goods to get where they were going. But when the demand for bioresorbable polymers was raised in the medical and pharmaceutical sectors, the market for them began to rebound. The medical sector continued to function during the epidemic, supporting the world market. Following the start of the widespread vaccination campaign in 2021, additional developing countries expanded the manufacture of bioresorbable polymers.

The polylactic acid segment is expected to be the largest during the forecast period:

The polylactic acid segment is estimated to have a lucrative growth, due to its excellent process ability and mechanical strength, PLA is one of the most commercially viable biopolymers. PLA is non-toxic, biodegradable, recyclable, compostable, and is metabolised by living things. It is superior to conventional polymers in a number of ways, including improved thermal processability and the ability to be processed through a variety of moulding processes. The two primary subtypes of PLA are PLLA and PDLLA.

The orthopedic devices segment is expected to have the highest CAGR during the forecast period:

The orthopedic devices segment is anticipated to witness the highest CAGR growth during the forecast period, due to the major use of resorbable polymers is in orthopaedics. The high growth in this application is attributed to a number of factors, including an increase in the prevalence of orthopaedic disorders, an improvement in standard of living brought on by rising per capita income, rising healthcare spending, a rise in the demand for higher quality medical care, and increased awareness of bioresorbable stents in numerous nations around the world.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the rapid economic expansion of developing nations and rising per capita disposable income. The presence of high-growth economies like India, China, and Japan, as well as the quick ageing of the population, the rising number of hospitals, supportive reimbursement policies, the implementation of helpful government initiatives, rising per capita income, significant investments in the healthcare sector, demand for cutting-edge surgery products, and the expansion of private hospitals into rural areas are additional factors driving the market in APAC.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to rising product use in orthopaedics and medication delivery applications. The bioresorbable polymers market in North America is further fueled by the U.S., which serves as a significant centre for research and development in the healthcare sector. Additionally, it is anticipated that the expanding need for polymers in orthopaedics and drug delivery applications, together with rising healthcare spending, would drive up demand for the product in the area the expanding need for polymers in orthopaedics and drug delivery applications, as well as more healthcare spending, are all expected to drive up product demand in this region.

Key players in the market

Some of the key players profiled in the Bioresorbable Polymers Market include Evonik Industries AG, Foster Corporation, Ashland Global Holdings Inc., REVA Medical, LLC, Bezwada Biomedical, LLC, BMG Incorporated, Foryou Medical Devices Co., Ltd, Musashino Chemical Laboratory, Ltd., Henan Xinghan Biotechnology Co. Ltd., KLS Martin Group, DSM Biomedical, Corbion N.V., Zeus Industrial Products, Abbott, 3D Biotek LLC, Sunstar Suisse S.A. and Futerro

Key Developments:

In June 2023, Evonik launches new TEGO® Rad 2550 slip and defoamer additive for radiation-curing inks and coatings, The new TEGO® Rad 2550 is a clear, low viscosity liquid that effectively reduces static and dynamic surface tension in both conventional UV- and LED-cured formulations.

In June 2023, Evonik expands global alkoxides business with new Singapore plant. In future, alkoxide catalysts will also play a bigger role in the circular economy through their use in the chemical recycling of PET plastics.

Product Types Covered:

  • Polysaccharides
  • Polylactic acid
  • Polyglycolic acid
  • Polycaprolactone
  • Poly(lactic-co-glycolic acid) (PLGA)
  • Agro-Polymers
  • Bio-Polyesters
  • Other Product Types

Applications Covered:

  • Orthopedic devices
  • Drug delivery
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bioresorbable Polymers Market, By Product Type

  • 5.1 Introduction
  • 5.2 Polysaccharides
  • 5.3 Polylactic acid
    • 5.3.1 Poly-d,l-lactic acid (PDLLA)
    • 5.3.2 Poly (l-lactic) acid (PLLA)
  • 5.4 Polyglycolic acid
  • 5.5 Polycaprolactone
  • 5.6 Poly(lactic-co-glycolic acid) (PLGA)
  • 5.7 Agro-Polymers
  • 5.8 Bio-Polyesters
  • 5.9 Other Product Types

6 Global Bioresorbable Polymers Market, By Application

  • 6.1 Introduction
  • 6.2 Orthopedic devices
    • 6.2.1 Hip
    • 6.2.2 Knee
    • 6.2.3 Trauma
    • 6.2.4 Spine
  • 6.3 Drug delivery
    • 6.3.1 Parenteral
    • 6.3.2 Oral
    • 6.3.3 Other Drug deliveries
  • 6.4 Other Applications

7 Global Bioresorbable Polymers Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Evonik Industries AG
  • 9.2 Foster Corporation
  • 9.3 Ashland Global Holdings Inc.
  • 9.4 REVA Medical, LLC
  • 9.5 Bezwada Biomedical, LLC
  • 9.6 BMG Incorporated
  • 9.7 Foryou Medical Devices Co., Ltd
  • 9.8 Musashino Chemical Laboratory, Ltd.
  • 9.9 Henan Xinghan Biotechnology Co. Ltd.
  • 9.10 KLS Martin Group
  • 9.11 DSM Biomedical
  • 9.12 Corbion N.V.
  • 9.13 Zeus Industrial Products
  • 9.14 Abbott
  • 9.15 3D Biotek LLC
  • 9.16 Sunstar Suisse S.A.
  • 9.17 Futerro

List of Tables

  • Table 1 Global Bioresorbable Polymers Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
  • Table 4 Global Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
  • Table 5 Global Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
  • Table 6 Global Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
  • Table 7 Global Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
  • Table 8 Global Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
  • Table 9 Global Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
  • Table 10 Global Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
  • Table 11 Global Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
  • Table 12 Global Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 13 Global Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
  • Table 14 Global Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
  • Table 15 Global Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
  • Table 16 Global Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
  • Table 17 Global Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
  • Table 18 Global Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
  • Table 19 Global Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
  • Table 20 Global Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
  • Table 21 Global Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
  • Table 22 Global Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
  • Table 23 Global Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 24 North America Bioresorbable Polymers Market Outlook, By Country (2021-2030) ($MN)
  • Table 25 North America Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 26 North America Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
  • Table 27 North America Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
  • Table 28 North America Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
  • Table 29 North America Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
  • Table 30 North America Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
  • Table 31 North America Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
  • Table 32 North America Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
  • Table 33 North America Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
  • Table 34 North America Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
  • Table 35 North America Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 36 North America Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
  • Table 37 North America Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
  • Table 38 North America Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
  • Table 39 North America Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
  • Table 40 North America Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
  • Table 41 North America Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
  • Table 42 North America Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
  • Table 43 North America Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
  • Table 44 North America Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
  • Table 45 North America Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
  • Table 46 North America Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 47 Europe Bioresorbable Polymers Market Outlook, By Country (2021-2030) ($MN)
  • Table 48 Europe Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 49 Europe Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
  • Table 50 Europe Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
  • Table 51 Europe Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
  • Table 52 Europe Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
  • Table 53 Europe Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
  • Table 54 Europe Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
  • Table 55 Europe Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
  • Table 56 Europe Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
  • Table 57 Europe Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
  • Table 58 Europe Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 59 Europe Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
  • Table 60 Europe Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
  • Table 61 Europe Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
  • Table 62 Europe Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
  • Table 63 Europe Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
  • Table 64 Europe Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
  • Table 65 Europe Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
  • Table 66 Europe Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
  • Table 67 Europe Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
  • Table 68 Europe Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
  • Table 69 Europe Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 70 Asia Pacific Bioresorbable Polymers Market Outlook, By Country (2021-2030) ($MN)
  • Table 71 Asia Pacific Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 72 Asia Pacific Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
  • Table 73 Asia Pacific Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
  • Table 74 Asia Pacific Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
  • Table 75 Asia Pacific Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
  • Table 76 Asia Pacific Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
  • Table 77 Asia Pacific Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
  • Table 78 Asia Pacific Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
  • Table 79 Asia Pacific Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
  • Table 80 Asia Pacific Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
  • Table 81 Asia Pacific Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 82 Asia Pacific Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
  • Table 83 Asia Pacific Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
  • Table 84 Asia Pacific Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
  • Table 85 Asia Pacific Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
  • Table 86 Asia Pacific Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
  • Table 87 Asia Pacific Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
  • Table 88 Asia Pacific Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
  • Table 89 Asia Pacific Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
  • Table 90 Asia Pacific Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
  • Table 91 Asia Pacific Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
  • Table 92 Asia Pacific Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 93 South America Bioresorbable Polymers Market Outlook, By Country (2021-2030) ($MN)
  • Table 94 South America Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 95 South America Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
  • Table 96 South America Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
  • Table 97 South America Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
  • Table 98 South America Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
  • Table 99 South America Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
  • Table 100 South America Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
  • Table 101 South America Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
  • Table 102 South America Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
  • Table 103 South America Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
  • Table 104 South America Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 105 South America Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
  • Table 106 South America Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
  • Table 107 South America Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
  • Table 108 South America Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
  • Table 109 South America Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
  • Table 110 South America Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
  • Table 111 South America Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
  • Table 112 South America Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
  • Table 113 South America Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
  • Table 114 South America Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
  • Table 115 South America Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 116 Middle East & Africa Bioresorbable Polymers Market Outlook, By Country (2021-2030) ($MN)
  • Table 117 Middle East & Africa Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 118 Middle East & Africa Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
  • Table 119 Middle East & Africa Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
  • Table 120 Middle East & Africa Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
  • Table 121 Middle East & Africa Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
  • Table 122 Middle East & Africa Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
  • Table 123 Middle East & Africa Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
  • Table 124 Middle East & Africa Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
  • Table 125 Middle East & Africa Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
  • Table 126 Middle East & Africa Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
  • Table 127 Middle East & Africa Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 128 Middle East & Africa Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
  • Table 129 Middle East & Africa Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
  • Table 130 Middle East & Africa Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
  • Table 131 Middle East & Africa Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
  • Table 132 Middle East & Africa Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
  • Table 133 Middle East & Africa Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
  • Table 134 Middle East & Africa Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
  • Table 135 Middle East & Africa Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
  • Table 136 Middle East & Africa Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
  • Table 137 Middle East & Africa Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
  • Table 138 Middle East & Africa Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 139 Middle East & Africa Snowmobile Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 140 Middle East & Africa Snowmobile Market Outlook, By Engine Type (2021-2030) ($MN)
  • Table 141 Middle East & Africa Snowmobile Market Outlook, By Two-Stroke Engine (2021-2030) ($MN)
  • Table 142 Middle East & Africa Snowmobile Market Outlook, By Four-Stroke Engine (2021-2030) ($MN)
  • Table 143 Middle East & Africa Snowmobile Market Outlook, By Engine Capacity (2021-2030) ($MN)
  • Table 144 Middle East & Africa Snowmobile Market Outlook, By <500 CC (2021-2030) ($MN)
  • Table 145 Middle East & Africa Snowmobile Market Outlook, By 500 CC to 800 CC (2021-2030) ($MN)
  • Table 146 Middle East & Africa Snowmobile Market Outlook, By 800 CC & above (2021-2030) ($MN)
  • Table 147 Middle East & Africa Snowmobile Market Outlook, By Seating (2021-2030) ($MN)
  • Table 148 Middle East & Africa Snowmobile Market Outlook, By Single Seater (2021-2030) ($MN)
  • Table 149 Middle East & Africa Snowmobile Market Outlook, By Two Seater (2021-2030) ($MN)
  • Table 150 Middle East & Africa Snowmobile Market Outlook, By Three Seater (2021-2030) ($MN)
  • Table 151 Middle East & Africa Snowmobile Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 152 Middle East & Africa Snowmobile Market Outlook, By Franchised Stores (2021-2030) ($MN)
  • Table 153 Middle East & Africa Snowmobile Market Outlook, By Sports Stores (2021-2030) ($MN)
  • Table 154 Middle East & Africa Snowmobile Market Outlook, By Speciality Stores (2021-2030) ($MN)
  • Table 155 Middle East & Africa Snowmobile Market Outlook, By Online (2021-2030) ($MN)
  • Table 156 Middle East & Africa Snowmobile Market Outlook, By Other Sales Channels (2021-2030) ($MN)